AM Investment Strategies’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-16,100
| Closed | -$504K | – | 109 |
|
|
2023
Q4 | $504K | Sell |
16,100
-900
| -5% | -$28.2K | 0.14% | 66 |
|
|
2023
Q3 | $354K | Hold |
17,000
| – | – | 0.12% | 68 |
|
|
2023
Q2 | $407K | Hold |
17,000
| – | – | 0.13% | 63 |
|
|
2023
Q1 | $320K | Hold |
17,000
| – | – | 0.11% | 69 |
|
|
2022
Q4 | $271K | Hold |
17,000
| – | – | 0.1% | 73 |
|
|
2022
Q3 | $278K | Hold |
17,000
| – | – | 0.1% | 69 |
|
|
2022
Q2 | $240K | Hold |
17,000
| – | – | 0.08% | 80 |
|
|
2022
Q1 | $412K | Hold |
17,000
| – | – | 0.11% | 73 |
|
|
2021
Q4 | $397K | Sell |
17,000
-200
| -1% | -$4.67K | 0.1% | 81 |
|
|
2021
Q3 | $286K | Sell |
17,200
-1,400
| -8% | -$23.3K | 0.08% | 88 |
|
|
2021
Q2 | $454K | Buy |
18,600
+800
| +4% | +$19.5K | 0.12% | 72 |
|
|
2021
Q1 | $459K | Hold |
17,800
| – | – | 0.13% | 69 |
|
|
2020
Q4 | $952K | Buy |
17,800
+700
| +4% | +$37.4K | 0.29% | 42 |
|
|
2020
Q3 | $705K | Buy |
+17,100
| New | +$705K | 0.25% | 48 |
|